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Abstract
Background: Patellofemoral pain syndrome (PFPS) is a common musculoskeletal disorder. There is little
consensus on the etiology, but one explanatory model suggests that PFPS can be caused by referred pain.
Neurodynamic tests are used to explore the mechanosensitivity of peripheral nerves, and previous studies
have shown a relationship between increased mechanosensitivity and anterior knee pain by using the femoral
slump test (FST). Previously the prone knee bend test (PKB) does not appear to have been included. The
main purpose of this pilot study was to examine whether there was an identifiable difference in mechanosensitivity
between left and right sides that could be identified using both the PKB and FST tests for the femoral nerve in patients
with unilateral PFPS.
Methods: This cross-sectional pilot study tested 12 patients with unilateral PFPS for altered mechanosensitivity using
both PKB and FST. The pain-free knee was used as a control. The selected test procedures were similar to those
clinicians use in everyday practice.
Results: 8 and 4 of the 12 patients were found to have increased levels of mechanosensitivity in the PFPS leg
using the PKB and FST, respectively. Both tests provoked stronger pain in the leg with PFPS compared with
the asymptomatic leg (p < 0.05 Wilcoxon Signed Rank Test). The symptoms were more often located in the
anterior knee, with structural differentiation by neck flexion appearing to increase the symptoms more when
testing the leg with PFPS.
Conclusions: Although the reliability of the tests is unknown and the study sample size was small, the PKB
and FST test procedures used in clinical practice appear capable of revealing altered mechanosensitivity in
unilateral PFPS patients. The PKB test appears to detect mechanosensitivity in more patients than the FST. We
recommend including both tests in future larger blinded controlled studies which should also assess reliability
of the tests.
Trial registration: ISRCTN 12473526. Registered 20 May 2015, retrospectively registered.
Keywords: Anterior knee pain, Mechanosensitivity, Femoral nerve test, Femoral slump test, Slump knee bend
test, Prone knee bend test
Background
Anterior knee pain from patellofemoral pain syndrome
(PFPS) is a common musculoskeletal disorder. The main
symptom is pain during activity, although there are large
variations in the type and level. PFPS tends to affect ac-
tive young people and can become a long-lasting health
issue that prevents patients from living an active life [1].
There is little consensus on the etiology and manage-
ment [2, 3]. Two models have been presented to explain
the cause of PSFS. The first model explains PFPS by bio-
mechanical malalignment, muscle weakness, and over-
loading of the joint structures and the surrounding
patella retinaculum [1, 4–7]. The second model suggests
that PFPS can be a result of referred pain from neural
structures with nerves from the lumbar plexus causing
pain in the anterior part of the knee [8–10].
Several studies have provided new insight into PFPS
and support that neurogenic dysfunctions might be
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involved [3, 11–13]. Elevated levels of local neural
markers (substance P and neural growth factor) have
been found in the patellar tendon in patients with “jum-
per’s knee” (a similar condition), indicating the presence
of neurogenic inflammation [14]. Dysfunction in the af-
ferent nerves of PFPS patients has been found when
using quantitative sensory testing [15]. Immediate pain
relief in the knee after manipulation of the back in pa-
tients with PSFS has also been reported [16]. These find-
ings can be used to question the pain mechanism in
PFPS.
Several clinicians seem to have changed their thinking
about PFPS from being a pure “local” mechanical prob-
lem to being more the result of sensitization in the ner-
vous system. Due to courses and textbooks on the topic,
several therapists have also implemented neurodynamic-
tests and treatment for musculoskeletal conditions in
both the upper and lower extremities. The purpose of
using neurodynamic tests has been to explore the ner-
vous tissue’s ability to tolerate mechanical force and
traction. If the test reveals increased mechanosensitivity
(i.e., stronger symptoms), it is interpreted as neurogenic
dysfunction [9, 10, 17, 18].
Neuorodynamic tests are intended to move neural
structures and mechanically apply tension to them. This
tension is supposed to arouse a normal positive response
that evokes neurogenic symptoms [10]. If the neural
structures have altered mechanosensitivity the following
abnormal responses have been described: reduced range
of movement, stronger pain respons, reproduction of the
patients current symptoms when comparing the re-
sponse in the painful extremity with the asymptomatic
extremity [9, 10, 19, 20]. The neurodynamic tests are
well known among clinicians but are most often used in
patients in which nerve root compressions are sus-
pected. The tests are quick and easy to perform. The
prone knee bend test (PKB) and the femoral slump test
(FST) (Figs. 2 and 3) are used to identify mid-lumbar
nerve root compressions in patients with lower back
pain [21, 22]. However, these tests are seldom used to
examine patients with anterior knee pain. Nerves from
the lumbar-plexus and primarily the femoral nerve in-
nervate the anterior thigh and knee, which means that
examination of the femoral nerve could be useful in pa-
tients with PFPS. Butler and Shacklock indicate that
both tests could be relevant to use for patients with an-
terior knee pain [9, 10].
Various studies have explored the association between
conditions in the lower extremities and dysfunctions of
the femoral nerve [20, 23, 24]. Lai et al. explored
mechanosensitivity of the femoral nerve, using the FST
in patients with anterior knee pain and found the speci-
ficity to be above 0.75 [24]. Lin et al. examined neurody-
namic responses to the FST in patients with anterior
knee pain syndrome. They found increased mechanosen-
sitivity of the femoral nerve in patients with anterior
knee pain presenting with a positive FST [20]. Huang et
al. found that involving mobilization of the femoral
nerve could be beneficial in treatments for PFPS patients
with a positive FST [13].
There seems to be a lack of consensus on how to per-
form and interpret the different neurodynamic tests, as
well as how to standardize and grade mechanosensitivity.
Furthermore, there are different definitions of a positive
test. However, there seems to be agreement that in-
creased mechanosensitivity should be evaluated in each
test individually and that the responses should be com-
pared with the contralateral side [10, 17, 24, 25]. Lin et
al. compared the neurodynamic responses between sub-
jects with and without anterior knee pain. This study
and Lai et al. used testing procedures in laboratory envi-
ronments that included the use of several straps to
maintain the patient’s position. It would be of interest to
explore whether easier test procedures similar to what is
used in clinical practice could reveal increased mechano-
sensitivity. To our knowledge, no study on PFPS has
used procedures similar to clinical practice and com-
pared the mechanosensitivity in the painful and the
asymptomatic leg in patients with unilateral PFPS. Fur-
thermore, we have not been able to find studies that in-
clude the PKB test.
The main purpose of this pilot study was to examine
whether a side difference in mechanosensitivity could be
identified using both the PKB and the FST tests for the
femoral nerve in patients with unilateral PFPS and to
use the patient’s asymptomatic leg as control. The se-
lected test procedures are similar to what clinicians use
in everyday practice. We hypothesized that the responses
would be different in the two legs, that there would be a
smaller range of motion (ROM) at the onset of the pain/
discomfort, stronger pain at the end of the ROM, and
that the participants’ anterior knee pain could be repro-
duced in the PFPS leg. We also hypothesized that there
would be a positive structural differentiation in the af-
fected leg, assessed in the FST.
Methods
The participants in this cross-sectional pilot study were
12 patients with unilateral PFPS who were between 18
and 44 years old. All were recruited from a physiother-
apy clinic in primary health care and can be seen as a
convenience sample. We identified relevant patients
from the clinic’s waiting list, contacted them by tele-
phone, and asked them about participation. An interview
and a clinical examination were used to confirm the
diagnosis and fulfillment of the inclusion criteria.
The inclusion criteria were: 1) a history of unilateral
anterior knee pain located around the patella and lasting
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for more than 3months, 2) the ability to participate in
normal daily activities, 3) pain at rest, during daily activ-
ities (such as knee bends or walking on stairs), or when
performing sports or exercise activities, and 4) no symp-
toms in the other leg, which was used as an asymptom-
atic control. Patients with known intra-articular
disorders, previous surgery or trauma in the legs, or a
knee injection during the last 3 months were excluded
from participation. During the inclusion process, two pa-
tients were excluded: one because of trauma and one
with a neurological diagnosis. The Regional Committee
for Medical and Health Research Ethics approved the
study (2010/819–4).
Self-reported questionnaire
A pain drawing was used to identify the location of pain,
confirm the knee pain, and explore the presence of pain
in other areas of the body. Pain intensity over the last 2
weeks was examined by a Visual Analogue Scale (VAS;
0 = no pain, 10 = worst pain). The Norwegian version of
the modified Cincinnati Knee Rating System question-
naire (CRS) was used to obtain information about pain
and function. The self-administered CRS contains 12
questions about knee pain, swelling, and function, and a
sum score is made (0–100; 100 is best). The CRS out-
come is evaluated as poor (< 30), fair (30–54), good (55–
79), or excellent (> 80). We also calculated two CRS sub-
scores for pain and activity. The maximum in each sub-
score was 20 points (the best score). The CRS has
previously been validated in patients with chronic knee
pain [26, 27].
Functional test
To evaluate the participants’ function, we used a test in-
cluding both weight bearing and knee bending since
these activities commonly aggravate the pain in PFPS pa-
tients. Loudon et al. found the step down test to be the
most sensitive and reliable test out of five different
performance-based tests. Furthermore, they found it to
be the only test to discriminate between PFPS patients
and controls and reported 100% symmetry between the
legs in people with no knee pain [28]. Studies have also
reported significant lower mean step rates in the affected
legs of patients with unilateral pain [3, 28].
We explored whether the test revealed asymmetry be-
tween the affected and unaffected leg. The participants
performed single leg squats from a 20-cm-high step.
They were instructed to go deep enough for the heel on
the other leg to touch the floor and then to return to the
starting position (Fig. 1). The number of repetitions per-
formed in 30 s was recorded. Both legs were tested, and
the difference in number was recorded.
Neurodynamic tests
We used the PKB and FST to examine the mechanosen-
sitivity of the femoral nerve. The PKB tested the femoral
nerve in a prone position (Fig. 2), and the FST tested the
femoral nerve in a side-lying position (Fig. 3) [9, 29]. We
used test procedures in accordance with the PKB and
Fig. 1 Step down test
Fig. 2 Prone knee bend test
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the slump knee bend test described by Butler [9]. We
registered four components with responses: 1) the loca-
tion of the pain, 2) the ROM (in degrees) at the onset of
pain/discomfort, 3) the level of pain (on NPRS) at end of
the ROM, and 4) structural differentiation with neck
flexion (used during the performance of the FST). A
goniometer was used to measure the ROM of the knee
and the hip.
To obtain all measurements as positive numbers, we
measured the hip-extension ROM in the FST using a
different method. We started measuring extension from
90 degrees of hip flexion (i.e., 90 degrees of flexion was
defined as the zero point for extension). From this pos-
ition, hip extension was passively performed until the
patient reported pain or discomfort. At this point, we
recorded the ROM in degrees. For example, if the pa-
tient were able to extend their hip to zero degrees of ex-
tension, the measurement would be noted as 90 degrees.
The level of pain was scored with a numeric pain rat-
ing scale (NPRS; scores from 0 to 10: no pain to worst
pain ever). Each participant was tested twice with a
break of 45 min in between. The average of the re-
sponses in each leg (ROM and NPRS) in the two exami-
nations was used in the analyses (see Table 1 for a
description). The same therapist (therapist 1) examined
all participants with the help of one assistant (therapist 2).




The neurodynamic tests can reproduce pain or discom-
fort in different bodily areas. If the tests reproduced the
patient’s actual pain in the actual area, we considered it
as a clinically important response. During the tests, the
patients reported pain or discomfort in different areas
like the knee, thigh, groin, hip, and back, as well as com-
binations of pain areas. For the analysis, we categorized
the pain locations as symptom areas involving anterior
knee pain (scored as 1) and symptom areas not involving
the knee (scored as 0).
Range of motion (ROM)
The ROM when pain or discomfort was first perceived
was measured by a universal goniometer, and the results
were compared between the affected and control legs.
Various standard errors of measurement have been
Fig. 3 Femoral slump test
Table 1 Description of procedures
Prone knee bend test (PKB) Femoral slump test (FST)
1 Patient in prone position with hips in neutral position. Patient in side-lying position. Lower leg held in 90 degrees of hip flexion
and stabilized by the patient’s hands. The trunk is in a fully flexed pos-
ition with the head in a neutral position.
2 Therapist 1 stabilizes the patient’s pelvis with one hand with the other
hand placed distally at the tibia. The knee is flexed until the onset of
pain/discomfort.
Therapist 1 stands behind the patient at the level of the pelvis. One
hand stabilizes the pelvis, and the other supports the knee, which is in
90 degrees of flexion. Patient’s foot is placed on the side of the
therapist’s trunk. From a flexed hip position, the therapist then extends
the hip until the onset of pain/discomfort.
3 Patient describes the location of the pain/discomfort (knee, thigh,
groin, back, other). The response is noted by therapist 2.
Patient describes the location of the pain/discomfort (knee, thigh, groin,
back, other). The response is noted by therapist 2.
4 Therapist 2 measures flexion ROM in the knee with a universal
goniometer.
Therapist 2 measures extension ROM in the hip with a universal
goniometer (starting point/0 degrees of extension is chosen at 90
degrees of hip flexion, and extension is measured from here).
5 Therapist 1 then flexes the knee until the end of the ROM Therapist 1 then extends the hip until end of the ROM
6 The patient is asked to grade the pain/discomfort on NPRS The patient is asked to grade the pain/discomfort on NPRS
7 The patient is asked to flex the neck and also to tell if their pain/
discomfort is changing. The response is noted.
PKB Prone knee bend test
FST Femoral slump test
ROM Range of motion
NPRS Numeric pain rating scale
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reported for the universal goniometer (0.52–2.66 degrees
in knee flexion and 2.8–3.5 degrees in hip extension).
We used a cut-off difference of 3 degrees for the PKB
and 4 degrees for the FST [30, 31]. Measurements lower
than these values were not interpreted as a difference.
Reduced ROM in the affected leg was interpreted as al-
tered mechanosensitivity in the femoral nerve and
scored as 1. No difference or increased ROM in the af-
fected leg compared with the control leg was scored 0.
Pain level
At the end of the ROM, we compared the pain intensity
(NPRS) registered in the affected and the asymptomatic
control legs. There is an international consensus that the
minimal important change (MIC) on the NPRS in
chronic pain patients should be more than 30%. Further-
more, a change of 2 units is defined as “much better,”
while a change of 1 unit is “slightly better” [32]. A differ-
ence of 1 or more on the NPRS between the two legs
was interpreted as a sign of mechanosensitivity. Patients
with stronger end-range pain (1 or more) in the affected
leg compared to the asymptomatic leg were scored as 1.
Less or equal pain in the affected leg compared with the
control leg was scored as 0.
Structural differentiation
Neck flexion was performed in conjunction with the
FST to explore possible changes in pain or discomfort.
Structural differentiation where neck flexion increases
distal pain or discomfort is generally interpreted as a
neurogenic symptom [8–10]. We recorded changes in
pain or discomfort caused by neck flexion as either ag-
gravation (scored as 1) or no change (scored as 0).
Level of increased mechanosensitivity
All components were scored and recorded for both neu-
rodynamic tests, and side-by-side comparison was used
to determine whether mechanosensitivity was increased.
We decided whether a high level of increased mechano-
sensitivty was present in the affected leg by using a sum
score of all three components for the PKB and all four
components for the FST for each patient. Furthermore,
we defined a maximum sum score of 3 on the PKB and
4/3 on the FST as a high level of increased
mechanosensitivity.
Statistical analyses
All analyses were performed using SPSS version 18 (IBM
Corp., New York, NY). Background data, pain areas, and
structural differentiation are presented as frequencies.
Pain and function scores are presented with the mean,
range, and standard deviations (SD). On the neurody-
namic tests, the ROM and pain responses are given as
the median and range since the data were skewed. The
differences between the affected leg and control legs
were tested using the Wilcoxon Signed rank test for
continuous variables (NPRS and ROM). The significance
level was set as p < 0.05.
Results
There were 12 participants in the study, which com-
prised 9 women and 3 men with a mean age of 32 (21–
42) years. Four participants reported unilateral knee pain
only (no pain in other bodily areas), four reported add-
itional pain in the back, and four reported additional
pain in other bodily areas (all recorded from the pain
drawings). Two of the participants also reported pain in
the posterior part of the affected knee. The knee pain
was most pronounced during activities such as stair
climbing, running, and jumping for all participants, but
four participants also reported pain during sitting.
The most predominant characteristics of the quality of
the knee pain were “aching” or “sharp.” The duration of
the pain varied from 4months to 5 years. According to
the modified CRS, the whole study sample had a fair
mean (SD) total score of 52.5 (18). The VAS for the last
14 days and the CRS score showed good correlation
(r = 0.69, p = 0.012). The participants had a lower
mean step rate of 19 with the affected leg versus 21
in the asymptomatic leg. Furthermore, 10 of the 12
patients had fewer repetitions with the affected leg
compared with the asymptomatic leg. Hence, there
was a non-significant difference between the painful
knee (PFPS) and asymptomatic knee with a p-value of
0.053 (Wilcoxon signed ranked test) (Table 2).
Results of neurodynamic tests
Rom
In the PKB, 9 of the 12 participants had decreased ROM
in the affected leg compared to the asymptomatic con-
trol leg. The median (range) ROM for the onset of pain
or discomfort was 123 (72–133) degrees of knee flexion
in the affected leg and 127 (84–140) degrees in the
asymptomatic leg. In the FST, only 2 of the 12
Table 2 Description of participants
Mean (SD) Range
Pain last 2 weeks
(VAS, cm)
3.8 (1.7) 1.0–6.5
Cincinnati knee score total (0–100) 52.5 (18) 24–81
Cincinnati knee score pain (0–20) 8.3 (2.7) 4–12








VAS Visual analogue scale
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participants had decreased ROM in the affected leg
compared to the asymptomatic leg. There was no signifi-
cant difference between groups for the ROM in either
test (Tables 3 and 4).
Pain area
The PKB provoked anterior knee pain more frequently
in the affected leg than the asymptomatic leg. There
were 10 participants who reported pain or discomfort
involving the anterior knee area when testing the affected
leg, whereas 3 reported the involvement of anterior knee
pain or discomfort when testing the asymptomatic leg. In
the FST, 6 participants reported pain or discomfort involv-
ing the anterior knee area when testing the affected leg,
whereas 3 reported the involvement of anterior knee pain
when testing the asymptomatic leg.
Pain or discomfort level
Of the 12 patients, 11 reported stronger end-range pain
when testing the affected leg compared to the asymp-
tomatic leg in the PKB. The median pain score was 3
(NPRS) in the affected leg and 2 in the unaffected leg.
The significant difference was 1 (p = 0.003). The differ-
ence was also significant in the FST, with a difference in
the NPRS score of 0.70 (p = 0.041). The median pain score
was 4.2 in the affected leg and 3.5 in the unaffected leg.
Structural differentiation using neck flexion (FST)
When testing the affected leg, 10 of the 12 patients reported
an aggravation of the pain during neck flexion, while 2
reported no change. When testing the asymptomatic control
leg, 7 participants experienced an aggravation of symptoms
with neck flexion, whereas 5 reported no change.
Sum scores
A high level of increased mechanosensitivity was found
in 8 of 12 patients on the PKB test. In these patients all
three of the components were positive (provocation of
knee pain, reduced ROM, and higher pain score on the
affected leg). Two participants had two positive compo-
nents. A high level of increased mechanosensitivity was
found in 4 of 12 patients on the FST test: only one par-
ticipant had all four components of the FST test positive
(provocation of knee pain, reduced ROM, higher pain
score, and aggravation of pain when flexing the neck),
while three participants had three out of four compo-
nents positive.
Table 3 Prone knee bend test-result
PKB-ROM PKB-PAIN LEVEL (NPRS) PKB-SYMPTOM AREA TOTAL
ID PKB -Rom 1 1 = reduced ROM. PKB-Rom 2 NPRS1 1 = stronger pain NPRS2 area 1 1 = knee pain area 2 PKB SUM
1 90 1 112 9 1 7.5 5 1 2 3
2 120.5 1 130 5 1 3.5 5 1 2 3
3 109.5 0 102.5 3 1 2 2 0 7 1
4 133 1 140 1 1 0 1 1 2 3
5 132 0 119 3 0 3 6 1 6 1
6 71.5 1 83.5 3 1 1.5 5 1 2 3
7 115 1 123 3 1 2 6 1 7 3
8 133 1 136 4.5 1 3.5 7 0 7 2
9 125 1 131 3 1 1.5 5 1 2 3
10 130 1 140 2 1 0 5 1 1 3
11 72 1 90 3 1 1 5 1 5 3
12 130 0 130 7 1 5 6 1 5 2
sum 9 11 10 8
median 123 (72–133) 127 (84–140) 3.0*(1.0–9.0) 2.0 (0–7.5)
p-value p = (0.068) p = (0.003)
ROM-1: range of motion (degrees) when first perceived symptoms in the affected leg
ROM-2: range of motion (degrees) when first perceived symptoms in the asymptomatic leg
1 = reduced ROM: smaller ROM in the affected leg with a difference of 4 degrees or more
NPRS-1: level of pain at end range of motion in the affected leg
NPRS-2: level of pain at end range of motion in the asymptomatic leg
1 = stronger pain: the level of pain in the affected leg was 1 or more on NPRS
Area-1: patients reported pain or discomfort in different areas in the affected leg
Area-2: patients reported pain or discomfort in different areas in the asymptomatic leg
(1 = knee, 2 = thigh, 3 = groin/hip, 4 = back, 5 = knee + 1 area, 6 = knee + 2 areas, 7 = other areas, not knee)
1 = knee pain: reproductions of symptoms involving knee pain in the affected leg (including 1, 5 or 6)
PKB-sum: all patients who scored 3
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Discussion
The results revealed somewhat different responses on
the two neurodynamic tests when testing the affected
and asymptomatic legs. The participants reported stron-
ger pain in the affected leg compared to the asymptom-
atic leg, particularly when tested with the PKB. Both the
PKB and the FST provoked more anterior knee symp-
toms in the affected leg. Furthermore, all 3 components
on the PKB were positive for 8 of the 12 participants
(pain area, ROM, pain intensity). Three or four compo-
nents of the FST were positive for four participants
(provocation of knee pain, reduced ROM, higher pain
score, and aggravation of pain when flexing the neck).
Altogether, these findings can be interpreted as signs of
increased mechanosensitivity in the femoral nerve in the
leg with PFPS.
To our knowledge, this pilot study is the first to in-
clude both the PKB and the FST when examining pa-
tients with PFPS, as well as the first to explore these
tests in a clinical setting. The PKB is often used in clin-
ical practice, particularly when examining patients with
low back pain, but we also consider this test to be rele-
vant for patients with anterior knee pain. In this small
sample of patients with unilateral anterior knee pain, the
PKB was more often positive in the affected leg and pos-
sibly revealed increased mechanosensitivity in more par-
ticipants than the FST did. This could be interpreted as
greater sensitivity in this test, but the result is not clear.
Since no study has explored the methodological quality
of the tests, our results must be interpreted with
caution.
The difference in responses on the two tests could also
be due to methodological differences in performing the
tests. The FST can be seen as more complex and difficult
for the examiner to carry out. The side-lying position
makes it more difficult for the examiner to control the
spinal flexion and the pelvic stability. According to
Shacklock, one common problem is creating sufficient
Table 4 Femoral slump test – result
FST- ROM FST- PAIN LEVEL FST - SYMPTOM AREA STRUCTURAL
DIFFERATION POSIIVE
TOTAL
Rom-1 Rom-2 NPRS-1 NPRS-2 Area-1 Area-2 Leg- 1 Leg −2 FST -SUM
ID 1 = reduced ROM. 1 = stronger pain 1 = knee pain yes yes
1 78 1 90 7 0 7 6 1 5 1 0 3
2 70 1 85 4 1 1 5 1 2 1 0 4
3 96 0 90 5.5 1 3 6 1 6 1 1 3
4 120 0 120 0 0 0 2 0 2 0 0 0
5 92 0 86 4 0 4 2 0 5 1 1 1
6 69 0 65 3.5 0 3.5 5 1 7 1 0 2
7 95 0 95 0 0 0 7 0 7 1 1 1
8 90 0 85 5.5 0 5.5 7 0 7 1 1 1
9 85 0 85 4.5 1 3.5 2 0 2 1 1 2
10 95 0 95 7 0 7 5 1 7 0 0 1
11 85 0 80 4 1 1 5 1 2 1 1 3
12 85 0 85 7 1 6 7 0 7 1 1 2
sum 2 5 6 10 7 4
median 87 (69–120) 86 (65–120) 4.2*(0–7.0) 3.5 (0–7.0)
p-value (p = 0.041)
ROM-1: range of motion (degrees) when first perceived symptoms in the affected leg
ROM-2: range of motion (degrees) when first perceived symptoms in the asymptomatic leg
1 = reduced ROM: smaller ROM in the affected leg with a difference of 4 degrees or more
NPRS-1: level of pain at end range of motion in the affected leg
NPRS-2: level of pain at end range of motion in the asymptomatic leg
1 = stronger pain: the level of pain in the affected leg was 1 or more on NPRS
Area-1: patients reported pain or discomfort in different areas in the affected leg
Area-2: patients reported pain or discomfort in different areas in the asymptomatic leg
(1 = knee, 2 = thigh, 3 = groin/hip, 4 = back, 5 = knee + 1 area, 6 = knee + 2 areas, 7 = other areas, not knee)





FST-sum: all patients who scored 3 or 4
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tension in the nervous system through the spinal flexion
[10]. This indicates that the PKB can be easier to per-
form, which might have influenced our results.
It is important to be aware that both tests may induce
stress in other tissues like the anterior thigh fascia and
muscles and cannot be considered as only testing fem-
oral nerve tension. To exclude the involvement of tissues
other than the nerves, the structural differentiation man-
euver has been described as essential [9, 10, 19]. Lin et
al. considered FST results to be positive when a positive
structural differentiation could be found. They also sug-
gested that PFPS patients who presented with positive
FST results had altered mechanosensitivity [20]. Since
no other study has used both tests, comparisons cannot
be made. However, our different findings on the two
tests might reveal different aspects of mechanosensitiv-
ity, and we recommend implementing both tests when
examining PFPS patients.
One major challenge when using neurodynamic tests
is that there is no consensus concerning the operational
definitions, how to interpret the responses on the differ-
ent tests, and how to grade the responses. Therefore, we
used four different components to define levels of
mechanosensitivity (pain area, ROM, pain intensity, and
structural differentiation). We compared the affected
and asymptomatic legs for each component and inter-
preted a positive side difference as a sign of altered
mechanosensitivity.
The 3 or 4 components are often considered when
interpreting the tests in clinical practice but have not been
used in studies as far as we know. The components are
used mainly in accordance with the description from But-
ler and Shacklock of how to interpret the neurodynamic
tests [9, 10]. Butler and Shacklock also include interpreta-
tions of other aspects like the quality of resistance and ob-
servation of movement of the pelvis. These components
seem to be more difficult to perform, evaluate, and inter-
pret, and we decided not to include them in this pilot
study. Since it is not known whether any of the 3 or 4
components are more relevant than the others, we de-
cided to calculate the sum score for each participant. We
considered a higher sum as a sign of a higher level of
mechanosensitivity. To our knowledge, no other study on
neurodynamic testing has used a sum of responses when
considering mechanosensitivity.
We found a significant but small mean difference in
pain on the NPRS between the legs using the PKB (p =
0.003). This difference of 33% exceeds the previously de-
fined MIC, of 30% [33]. The difference was also significant
in the FST with difference of the NPRS score of 0.70 (p =
0.041), but the MIC did not exceed 30% (17.6%). Inter-
national consensus literature has suggested that the MIC
in NPRS should be 2 [32, 33]. Therefore, the clinical sig-
nificance of these findings could be questioned.
No statistical difference was found in ROM. However,
we did find individual differences between affected and
asymptomatic legs in 9 of the 12 patients when using
the PKB, and these differences exceeded the standard
error of the instrument (the universal goniometer)
[30, 31]. The participants reported that both tests repro-
duced their actual knee symptoms. Reproduction of the
patient’s actual symptoms or symptom response in the
same region as the patients’ clinical pain has been
regarded as relevant [9, 10]. We also found that structural
differentiation aggravated the symptoms on the FST in the
affected leg more often (in 10 out of 12 patients). How-
ever, 7 participants also reported aggravation of the symp-
toms in the non-affected leg. This finding is also in
accordance with results from previous studies [10, 20, 23]
and could indicate that the structural differentiation man-
euver can aggravate neurogenic symptoms in the asymp-
tomatic (PFPS) limb as well.
The study participants had experienced PFPS for more
than 3months and could be characterized as chronic
pain patients [34]. Chronic pain is seen as a complex
phenomenon that involves pain mechanisms in the cen-
tral nervous system, as well as biopsychological factors.
Therefore, it is conceivable that central sensitization
may have been a contributory factor that might have in-
fluenced our results. On the step down test, we observed
a lower step down rate (not significant) on the affected
leg compared to the control leg in 10 out of 12 patients.
This finding contrasts with previous studies reporting
significant differences in step down rates between the af-
fected and unaffected legs [3, 28]. This could be due to
the low number of participants in the present study or
could also indicate participants with better function. How-
ever, our study sample reported pain intensity (VAS) and
CRS total scores that are in accordance with those of par-
ticipants in previous studies on PFPS [3, 20, 28].
Our pilot study and previous studies have reported
that there might be a neurogenic-dysfunction aspect to
PFPS [3, 11–13, 15]. However, there is no gold standard
for identifying neurogenic pain or dysfunction, but neu-
rodynamic tests are suggested to be useful for identifica-
tion [10, 20, 24]. Increased mechanosensitivity in the
femoral nerve indicates that PFPS patients could have a
neurogenic dysfunction. However, we have not revealed
either the location or the cause of the dysfunction. The
question remains in regard to whether PFPS is caused by
a local peripheral nerve injury (induced by inflammation
or entrapments along the femoral nerve) or by inflam-
mation or entrapment of a lumbar nerve root.
Sanchis-Alfonso and Rosello-Sastre found that ischemia
in the lateral patellar retinaculum may trigger neural in-
flammation and could cause anterior knee pain [12, 35].
Furthermore, it is well known that L3 or L4 nerve-root
problems can increase mechanosensitivity in the femoral
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nerve and thus cause anterior-thigh and knee pain
[21, 22]. In our study sample, four patients also reported
back pain in addition to their primary pain problem
(PFPS). Lower back pain is common in the adult popula-
tion, and this might be a random finding in this sample.
On the other hand, the possible relationship between
PFPS and lower back pain would be interesting to investi-
gate in futures studies.
Strength and limitations
The main limitation of the present study is the low
number of participants. Hence, the results should be
interpreted with caution. However, some of our findings
are in accordance with results from previous studies.
The use of the unaffected leg as an asymptomatic con-
trol could be debatable, but this way of preforming the
tests is used in daily clinical practice and should be
highly relevant for clinicians. The use of two different
tests is a strength, and the different findings might indi-
cate that the tests explore different aspects of mechano-
sensitivity. Hence, the results indicate that both tests
should be used in a larger study.
It has been shown that the act of repeating the tests
can influence the results [36]. We tried to reduce this
learning effect and the possibility of measurement errors
by repeating the tests only twice. We also allowed a
break of approximately 45 min between the tests. More-
over, we used the mean responses (ROM and NPRS) on
the tests in the two examinations.To our knowledge, no
studies have examined the test-retest reliability of the
two tests. This can bee seen as a weakness and we rec-
ommend that this should be included in future studies.
To obtain all measurements as positive numbers, we
measured and recorded the hip extension ROM using a
different method. Although we found it easier to meas-
ure hip extension with this method, it has not previously
been used and therfore the lack of reliability can be seen
as a weakness. Using one person for all examinations
can be seen as a strength with regard to the intratester
reliability, but it can also be seen as a weakness since
blinding was not possible.
Conclusion
In this pilot study, including patients with unilateral
PFPS, we found differences in responses between the
affected and asymptomatic legs using two different
neurodynamic tests. The results show that it is possible
that these patients had increased mechanosensitivity in
the femoral nerve in the affected leg compared with the
asymptomatic control leg. Particularly, in the PKB, 8 of
the 12 participants had a high level of mechanosensitivity
in the affected leg. This finding may indicate that altered
mechanosensitivity in the femoral nerve can be part of an-
terior knee pain. Although the reliability of the tests is
unknown and the study sample size was small, the PKB
and FST test procedures used in clinical practice appear
capable of revealing altered mechanosensitivity in unilat-
eral PFPS patients. Hence, the tests may be worth consid-
ering when examining PFPS patients. The neurodynamic
tests for femoral pain can easily be included in the stand-
ard assessment protocol. However, it is important to
measure all components carefully and to interpret the
findings with caution. Since this is a pilot study, we rec-
ommend that both tests should be included in a study
with larger samples and a control group of healthy
individuals. Further studies are needed to investigate
the neurodynamic tests and the relationship between
PFPS and mechanosensitivity.
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